(Q35112055)

English

SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer

scientific article

Statements

SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer (English)
William Douglas Figg

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit